Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials
Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.
This is a short extract from a report by Bloomberg. The full text stays with the publisher — follow the link to read it there.
Read at source
